Advertisement

Imaging, Ultrastructural Aspects, and Trace Elements in the Thalassemic Condrodystrophy

  • E. Giuzio
  • M. Bria
  • F. Romeo
  • M. Misasi
  • C. Brancati

Abstract

Bone diseases are often present in subjects affected by thalassemia major and appear with different pathological features during growth or adult age [1], According to anatomopathological standards, the group of bone diseases observed during growth are characterized by cartilaginous lesions due mainly to both premature and asymmetrical fusion of the metaphyseal cartilage, while those observed in adults are expressed by skeleteal lesions [2–4]. In this paper we evaluate the lesions involving both the distal metaphysis of the femur and the proximal metaphysis of the tibia in thalassemic children between 8 and 11 years of age.

Keywords

Thalassemic Patient Thalassemia Major Femoral Metaphysis Distal Metaphysis Ultrastructural Aspect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Giuzio E, Bria M, Brancati C (1991) Le alterazioni scheletriche nella thalassemia major. GIOT 17: 277–283Google Scholar
  2. 2.
    Colavita M, Orazi C, Danza SM, Falappa P, Fabbri R (1987) Premature epiphyseal fusion and extramedullary hematopoiesis in thalassemia. Skeletal Radio 16: 533–538CrossRefGoogle Scholar
  3. 3.
    Currarino G, Erlandom M (1964) Premature fusion of epiphysis in Cooley anemia. Bone Joint Surg 83: 656–664Google Scholar
  4. 4.
    Esposito L, Ferrara M, Furante A (1976) Rilievi sull’accrescimento staturale e sulle maturazione scheletrica sulla talassemia mayor in rapporto alia terapia emotrasfusiva. Pediatria 84: 235–246PubMedGoogle Scholar
  5. 5.
    Podda G, Fodde M, Pirastu GF (1987) Preliminari considerazioni sulle alterazioni scheletriche in pazienti affetti da talassemia major trattati con deferoxamina. Atti 3rd SIRMN, Cagliari, pp 311–315Google Scholar
  6. 6.
    Brill PW, Winchester P, Giardina PJ (1991) Deferoxamine - induced bone dysplasia in patients with thalassemia major. A JR 156: 561–565Google Scholar
  7. 7.
    Orzincolo C, Scutellari P, Castaldi G (1992) Growth plate injury of the long bones in treated pthalassemia. Skeletal Radiol 21: 39–44PubMedCrossRefGoogle Scholar
  8. 8.
    De Virgillis S, Congia M, Frau F (1989) Deferoxamine-induced growth retardation in patients with thalassemia major. J Pediatr 113: 661Google Scholar
  9. 9.
    Model B, Berdoukas V (1984) The clinical approach to thalassaemia. Grune and Stratton New-YorkGoogle Scholar
  10. 10.
    Giuzio E, Bria M, Bisconte MG, Brancati C L’Osteopenia nei thalassemici politrasfusi. Nostra esperienza. Chir Organi Mov 76: 369–374Google Scholar
  11. 11.
    Giuzio E, Bria M, Misasi M, Brancati L (1991) Le dismetrie degli arti inferiori nella thalassemia major. GIOT [suppl] 129–132Google Scholar
  12. 12.
    Middlemiss GM, Raper A (1966) Skeletal changes in the haemoglobinopathies. J Bone Joint Surg [Br] 48: 693–702Google Scholar
  13. 13.
    Radici M, Galloni O (1977) Le alterazioni scheletriche nella malattia di Cooley. Arch Osp S Anna 20: 885–889Google Scholar
  14. 14.
    Ramazzina E, Nardi A, Luisetto G, Chiavilli F (1986) Metabolismo minerale e scheletrico nella beta talassemia. Atti Accad Sci Ferrara 63: [Suppl] 251–263Google Scholar
  15. 15.
    Puxeddu L, Floris G, Murras MC (1984) II metabolismo calcico nell’osteopatia talassemica. Ortop Traumatol Oggi 4Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • E. Giuzio
  • M. Bria
  • F. Romeo
  • M. Misasi
  • C. Brancati

There are no affiliations available

Personalised recommendations